In the infiltrating cells, several known effects of c-MET, such as reducing organ fibrosis and upregulating pro-inflammatory cytokines [44, 45], might explain the favorable effect of c-MET in cHL. The gene discussed is MET; the disease is classic Hodgkin lymphoma.